Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.
作者： Wen-Hung Chung , Wan-Chun Chang , Yun-Shien Lee , Ying-Ying Wu , Chih-Hsun Yang
关键词: Dermatology 、 Case-control study 、 Population 、 Toxic epidermal necrolysis 、 Medicine 、 Pathology 、 Eosinophilia 、 Adverse effect 、 Genome-wide association study 、 Odds ratio 、 Pharmacogenetics
摘要: Importance The antiepileptic drug phenytoin can cause cutaneous adverse reactions, ranging from maculopapular exanthema to severe cutaneous adverse reactions, which include …
unirioja.es
nhri.org.tw参考文章(46)
Wan Mohd Nowalid Wan Khairina, Harris Abdullah Ngow, Roslan Harun, Rusli Ismail, Mohd Zaki Salleh, Lay Kek Teh, Wee Leng Lee, CYP2C9 polymorphism: Prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia Singapore Medical Journal. ,vol. 50, pp. 490- 493 ,(2009)
FDA: Epilepsy drugs may carry skin risks for Asians. JAMA. ,vol. 300, pp. 2845- ,(2008) , 10.1001/JAMA.2008.890
C. Depondt, P. Godard, R. S. Espel, A. L. Da Cruz, P. Lienard, M. Pandolfo, A Candidate Gene Study of Antiepileptic Drug Tolerability and Efficacy Identifies an Association of CYP2C9 Variants With Phenytoin Toxicity European Journal of Neurology. ,vol. 18, pp. 1159- 1164 ,(2011) , 10.1111/J.1468-1331.2011.03361.X
Joyce A. Goldstein, Clinical relevance of genetic polymorphisms in the human CYP2C subfamily British Journal of Clinical Pharmacology. ,vol. 52, pp. 349- 355 ,(2001) , 10.1046/J.0306-5251.2001.01499.X
Tai-Ming Ko, Wen-Hung Chung, Chun-Yu Wei, Han-Yu Shih, Jung-Kuei Chen, Chia-Hsien Lin, Yuan-Tsong Chen, Shuen-Iu Hung, Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome. The Journal of Allergy and Clinical Immunology. ,vol. 128, pp. 1266- 1276 ,(2011) , 10.1016/J.JACI.2011.08.013
Y Niinuma, T Saito, M Takahashi, C Tsukada, Mi Ito, N Hirasawa, M Hiratsuka, Functional characterization of 32 CYP2C9 allelic variants Pharmacogenomics Journal. ,vol. 14, pp. 107- 114 ,(2014) , 10.1038/TPJ.2013.22
Shuen-Iu Hung, Wen-Hung Chung, Shiou-Hwa Jee, Wen-Chieh Chen, Yun-Ting Chang, Woan-Ruoh Lee, Shu-Ling Hu, Meng-Tse Wu, Gwo-Shing Chen, Tak-Wah Wong, Pa-Fan Hsiao, Wei-Hsuan Chen, Han-Yu Shih, Wu-Hsiang Fang, Chun-Yu Wei, Yi-Hui Lou, Yau-Li Huang, Juei-Jueng Lin, Yuan-Tsong Chen, Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenetics and Genomics. ,vol. 16, pp. 297- 306 ,(2006) , 10.1097/01.FPC.0000199500.46842.4A
Sang-Heon Kim, Sang-Hoon Kim, Ho Joo Yoon, Dong Ho Shin, Sung Soo Park, Youn-Seup Kim, Jae-Seuk Park, Young Koo Jee, NAT2 , CYP2C9 , CYP2C19 , and CYP2E1 genetic polymorphisms in anti-TB drug-induced maculopapular eruption European Journal of Clinical Pharmacology. ,vol. 67, pp. 121- 127 ,(2011) , 10.1007/S00228-010-0912-4
Kenji Takanashi, Hitoshi Tainaka, Kaoru Kobayashi, Toshio Yasumori, Masakiyo Hosakawa, Kan Chiba, CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates. Pharmacogenetics. ,vol. 10, pp. 95- 104 ,(2000) , 10.1097/00008571-200003000-00001
Kaori Nakamoto, Judith R. Kidd, Robert D. Jenison, Curtis D. Klaassen, Yu-Jui Yvonne Wan, Kenneth K. Kidd, Xiao-bo Zhong, Genotyping and haplotyping of CYP2C19 functional alleles on thin-film biosensor chips Pharmacogenetics and Genomics. ,vol. 17, pp. 103- 114 ,(2007) , 10.1097/FPC.0B013E32801152C2